Last reviewed · How we verify
Regular Titration
At a glance
| Generic name | Regular Titration |
|---|---|
| Sponsor | University of Florida |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Glycemic Control After Antenatal Corticosteroids in Women With Pregestational and Gestational Diabetes (PHASE2)
- Veterans Affairs Pharmacist Heart Failure Medication Titration Project 2 (NA)
- A Clinical Study Evaluating the Safety, Tolerability, and Efficacy of MT1013 in Hemodialysis Subjects With Secondary Hyperparathyroidism (PHASE2)
- Optimizing Portal Hypertension With TIPS and Interval Metabolic Surgery for Advanced Liver Disease (PHASE4)
- Health Behavior Intervention for Adults With Type 1 Diabetes (NA)
- Strategy TO Prevent Decompensated Heart Failure (NA)
- Adaptive Dietary Intervention (ADI) for Asian Americans With Type 2 Diabetes (NA)
- Tirzepatide for Partial Lipodystrophy Treatment: A New Horizon in 2024 (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Regular Titration CI brief — competitive landscape report
- Regular Titration updates RSS · CI watch RSS
- University of Florida portfolio CI